According to a new report, published by KBV research, The Global eClinical solutions Market size is expected to reach $20.1 billion by 2028, rising at a market growth of 13.6% CAGR during the forecast period.
The Web-based (on-demand) Model market acquired the maximum revenue share in the Global eClinical Solutions Market by Delivery Mode in 2021, thereby, achieving a market value of $10.7 billion by 2028. The domination of the segment is the result of the benefits including ease of use, usability, and inexpensive initial investment. Because web-hosted items are highly adaptable, providers can alter the way that information is presented to different user groups. These products also have a higher degree of interoperability.
The Phase II market would showcase a CAGR of 13.8% during (2022 - 2028). This is because of an increasing number of medications successfully advancing to phase III. This is due to the significance of these systems in predicting future outcomes and eliminating medication candidates with the lowest likelihood of success.
The CDMS/EDC Solutions market is leading the Global eClinical Solutions Market by Product in 2021, thereby, achieving a market value of $6.9 billion by 2028. This is due to the high quality of information captured, streamlined data collection processes, and availability of effective data analysis. A crucial stage in clinical research is clinical data management (CDM), which produces high-quality, trustworthy, and statistically sound data from clinical trials. This significantly shortens the period of time between drug development and launch.
The Contract Research Organizations market would experience a CAGR of 14% during (2022 - 2028). This is the result of the pharmaceutical companies' propensity to cut overall spending, improve clinical trials, and streamline research workload. The advantages of outsourcing clinical trials to CROs are the driving force behind this market's rapid expansion.
The Asia Pacific market dominated the Global eClinical Solutions Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $5.0 billion by 2028. The Europe market is experiencing a CAGR of 13.1% during (2022 - 2028). Additionally, The North America market is estimated to grow at a CAGR of 12.9% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/eclinical-solutions-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Oracle Corporation, Anju Software, Inc., eClinical Solutions LLC, Castor EDC, Signant Health, Dassault Systemes SE, Parexel International Corporation (Phoenix Parentco, Inc.), Clario, BSI Life Sciences (Business Systems Integration AG) and MedNet Solutions
By Delivery Mode
By Product
By Clinical Trials Phase
By End User
By Geography
Companies Profiled
Unique Offerings 
